129 related articles for article (PubMed ID: 14510982)
1. A multiparameter flow cytometric analysis of the effect of bexarotene on the epidermis of the psoriatic lesion.
Franssen ME; Smit JV; Van Erp PE; Van De Kerkhof PC
Br J Dermatol; 2003 Sep; 149(3):506-12. PubMed ID: 14510982
[TBL] [Abstract][Full Text] [Related]
2. Novel functional multiparameter flow cytometric assay to characterize proliferation in skin.
Mommers JM; Goossen JW; van De Kerkhof PC; van Erp PE
Cytometry; 2000 Feb; 42(1):43-9. PubMed ID: 10679742
[TBL] [Abstract][Full Text] [Related]
3. Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis.
Mommers JM; van Rossum MM; van Erp PE; van De Kerkhof PC
Dermatology; 2000; 201(1):15-20. PubMed ID: 10971053
[TBL] [Abstract][Full Text] [Related]
4. Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin.
Smit JV; de Jong EM; van Hooijdonk CA; Otero ME; Boezeman JB; van de Kerkhof PC
J Am Acad Dermatol; 2004 Aug; 51(2):257-64. PubMed ID: 15280845
[TBL] [Abstract][Full Text] [Related]
5. Monitoring hyperproliferative disorders in human skin: flow cytometry of changing cytokeratin expression.
Franssen ME; Boezeman JB; Van De Kerkhof PC; Van Erp PE
Cytometry B Clin Cytom; 2004 Jan; 57(1):32-9. PubMed ID: 14696061
[TBL] [Abstract][Full Text] [Related]
6. Topical treatment of psoriatic plaques with 1 alpha, 24 dihydroxyvitamin D3: a multiparameter flow cytometrical analysis of epidermal growth, differentiation and inflammation.
Glade CP; van Erp PE; van Hooijdonk CA; Elbers ME; van de Kerkhof PC
Acta Derm Venereol; 1995 Sep; 75(5):381-5. PubMed ID: 8615058
[TBL] [Abstract][Full Text] [Related]
7. A left/right comparison of twice-daily calcipotriol ointment and calcitriol ointment in patients with psoriasis: the effect on keratinocyte subpopulations.
Franssen ME; de Jongh GJ; van Erp PE; van de Kerkhof PC
Acta Derm Venereol; 2004; 84(3):195-200. PubMed ID: 15202835
[TBL] [Abstract][Full Text] [Related]
8. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
Glade CP; Van Erp PE; Van De Kerkhof PC
Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis.
Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
J Exp Med; 1993 Oct; 178(4):1271-81. PubMed ID: 7690831
[TBL] [Abstract][Full Text] [Related]
10. Multiparameter flow cytometry as a tool to evaluate antipsoriatic therapy.
Glade CP; van Erp PE; Boezeman JB; van de Kerkhof PC
Br J Dermatol; 1997 Sep; 137(3):367-75. PubMed ID: 9349331
[TBL] [Abstract][Full Text] [Related]
11. Multiparameter flow cytometric characterization of epidermal cell suspensions prepared from normal and hyperproliferative human skin using an optimized thermolysin-trypsin protocol.
Glade CP; Seegers BA; Meulen EF; van Hooijdonk CA; van Erp PE; van de Kerkhof PC
Arch Dermatol Res; 1996 Apr; 288(4):203-10. PubMed ID: 8967793
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral bexarotene (targretin) on the minimal erythema dose for broadspectrum UVB light.
Smit JV; De Jong EM; Van De Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2003; 16(4):237-41. PubMed ID: 12784063
[TBL] [Abstract][Full Text] [Related]
13. Flow-cytometric characterization of normal versus psoriatic epidermis using improved cell separation methodology.
Seegers BA; Glade CP; van Hooijdonk CA; van Erp PE; de Jongh GJ; van de Kerkhof PC
Exp Dermatol; 2000 Aug; 9(4):266-70. PubMed ID: 10949548
[TBL] [Abstract][Full Text] [Related]
14. The effect of long-term treatment with tacalcitol on the psoriatic epidermis. A flow cytometric analysis.
Mommers JM; Castelijns FA; Seegers BA; Van Rossum MM; Van Hooijdonk CA; Van Erp PE; Van De Kerkhof PC
Br J Dermatol; 1998 Sep; 139(3):468-71. PubMed ID: 9767292
[TBL] [Abstract][Full Text] [Related]
15. Effects of systemic treatment with liarozole on cutaneous inflammation, epidermal proliferation and differentiation in extensive plaque psoriasis.
van Pelt JP; de Jong EM; de Bakker ES; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 1998; 11(2):70-9. PubMed ID: 9603657
[TBL] [Abstract][Full Text] [Related]
16. A phase II multicenter clinical trial of systemic bexarotene in psoriasis.
Smit JV; Franssen ME; de Jong EM; Lambert J; Roseeuw DI; De Weert J; Yocum RC; Stevens VJ; van De Kerkhof PC
J Am Acad Dermatol; 2004 Aug; 51(2):249-56. PubMed ID: 15280844
[TBL] [Abstract][Full Text] [Related]
17. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
18. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro.
Leigh IM; Navsaria H; Purkis PE; McKay IA; Bowden PE; Riddle PN
Br J Dermatol; 1995 Oct; 133(4):501-11. PubMed ID: 7577575
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments.
van Erp PE; Rijzewijk JJ; Boezeman JB; Leenders J; de Mare S; Schalkwijk J; van de Kerkhof PC; Ramaekers FC; Bauer FW
Am J Pathol; 1989 Nov; 135(5):865-70. PubMed ID: 2479273
[TBL] [Abstract][Full Text] [Related]
20. Clobetasol under hydrocolloid occlusion in psoriasis results in a complete block of proliferation and in a rebound of lesions following discontinuation.
Mommers JM; van Erp PE; van De Kerkhof PC
Dermatology; 1999; 199(4):323-7. PubMed ID: 10640842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
